Offer - Urjas Oil for just ₹ 1 X
Novorapid Flexpen 100U/ml is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Novorapid Flexpen 100U/ml safe for pregnant women?
There are no side effects of Novorapid in pregnant women.
Is the use of Novorapid Flexpen 100U/ml safe during breastfeeding?
Breastfeeding women can safely use Novorapid.
What is the effect of Novorapid Flexpen 100U/ml on the Kidneys?
Novorapid rarely harms the kidneys.
What is the effect of Novorapid Flexpen 100U/ml on the Liver?
Very few cases of side effects of Novorapid on the liver have been reported.
What is the effect of Novorapid Flexpen 100U/ml on the Heart?
Side effects of Novorapid rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Novorapid Flexpen 100U/ml unless your doctor advises you to do so -
Is this Novorapid Flexpen 100U/ml habit forming or addictive?
Novorapid Flexpen 100U/ml is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Novorapid Flexpen 100U/ml. So it is best to avoid driving.
Is it safe?
Yes, but take Novorapid Flexpen 100U/ml only as per medical advice.
Is it able to treat mental disorders?
No, Novorapid Flexpen 100U/ml is not used to treat mental disorders.
Interaction between Food and Novorapid Flexpen 100U/ml
Information is not available on the interaction of any foods with Novorapid Flexpen 100U/ml, due to a lack of research on this.
Interaction between Alcohol and Novorapid Flexpen 100U/ml
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Novorapid Flexpen 100U/ml.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; NovoLog (insulin aspart)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fiasp® (insulin aspart)
Highlights of Prescribing Information [Internet]: NovoLog (insulin aspart injection). Initial U.S. Approval: 2000